ORYZON presents blinded aggregate safety data from vafidemstat’s ongoing Phase IIb PORTICO trial in Borderline Personality Disorder

by Oryzon Genomics

Oryzon Genomics, S.A., a clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in diseases with strong unmet medical need, announced today that the company presented an ...

Read more

Researchers from the University's Biodiversity and Environment Institute , Magna and Emgrisa create a decontaminant that irreversibly eliminates Lindane

by Universidad de Navarra

It has been created a compound that facilitates the elimination of Lindane from landfills. Thanks to this research the compound can be used directly on soils to irreversibly decontaminate the affected...

Read more

Cómo mejorar los estilos de vida que afectan a la salud cerebral

by Universidad Politécnica de Madrid

El Grupo de Bioingeniería y Telemedicina de la UPM creará una plataforma tecnológica con inteligencia artificial para identificar los factores involucrados en el cumplimiento de hábitos beneficios...

Read more

Investigadores del IMIBIC caracterizan la obstrucción coronaria, una complicación de los procedimientos TAVI

by Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC)

Han llevado a cabo un estudio multicéntrico que concluye que la obstrucción coronaria es una complicación de los procedimientos TAVI, cuya incidencia ha permanecido estable a pesar de la experienci...

Read more

Renalyse has successfully closed an investment round of 1 M€ led by Mind the Gap and with participation from GENESIS Ventures and the Eurostars program

by GENESIS Biomed

Renalyse, also known as CreatSens Health, has concluded an investment round led by the Mind the Gap program of the Botín Foundation, with participation from GENESIS Ventures and the Eurostars program...

Read more

Onalabs incorporates Barça Innovation Hub (BIHUB) into its shareholding as a strategic partner

by Onalabs Inno-Hub

Onalabs Inno-Hub, the startup, a member of CataloniaBio & HealthTech, pioneer in the the development of medical devices capable of reading, measuring, and monitoring physical and biochemical physical ...

Read more

Blocking an immune molecule reduces tumor growth and prolongs survival in animal models of the most aggressive childhood cancer

by CIMA - Centro de Investigación Médica Aplicada

Spanish researchers from Cima and Clínica Universidad de Navarra together with the international cooperative group Diffuse Midline Glioma (DMG-ACT) demonstrate that TIM-3 inhibition promotes immune m...

Read more

Start a project to detect hepatitis C in asymptomatic patients

by Instituto de Investigación e Innovación Parc Taulí

With the aim of finding patients with undiagnosed hepatitis C, the researcher from the group Inflammatory bowel disease, liver disease and Helicobacter pylori from the Parc Taulí Research and Innovat...

Read more

Identifican un nuevo biomarcador de función cardiometabólica en pacientes con diabetes tipo II

by Hospital de la Santa Creu i Sant Pau

Revelan que los pacientes recién diagnosticados con diabetes tipo II presentan niveles elevados del receptor soluble LRP1 (sLRP1) y disminuidos del péptido natriurético auricular (ANP).

Read more

Identificado un mecanismo de acción no convencional en un receptor celular

by Parc Científic de Barcelona

Un trabajo del Instituto de Biología Molecular de Barcelona (IBMB-CSIC), con sede en el Parque Científico de Barcelona, describe cómo actúa el receptor TNFR Wengen y su papel en el desarrollo de l...

Read more

The Use of Rapid Tests to Diagnose Tuberculosis among People with HIV in Africa has Increased, but Barriers to Implementation Remain

by ISGlobal - Instituto de Salud Global de Barcelona

A study conducted by a student in ISGlobal-UB’s Master of Global identifies the main barriers for using the LF-LAM test as recommended by the WHO in countries with the highest disease burden

Read more

Vall d'Hebron hosts a meeting on advances in the diagnosis, surveillance and prevention of pertussis

by Vall d’Hebron

The European network EUPertStrain celebrates its annual meeting, focused on the study of the evolution of Bordetella pertussis, the bacterium responsible for this disease that can be very serious in c...

Read more
Subscribe to Directory
Write an Article

Recent News

El diagnóstico genético neonatal mejor...

Un estudio con datos de los últimos 35 años, ind...

Más de 1.500 cambios epigenéticos en e...

Un equipo de investigadores de la Universidad Juli...

Tuneable reverse photochromes in the sol...

A new technique allows the design of solid materia...

Highlight

Eosinófilos. ¿Qué significa tener val...

by Labo'Life

​En nuestro post hablamos sobre este interesante tipo de célula del...

Un estudio de INCLIVA muestra el efecto ...

by INCLIVA

Han desarrollado un estudio para evaluar la correlación entre el teji...

Photos Stream